Paul Tudor Jones Ptc Therapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 38,646 shares of PTCT stock, worth $1.75 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

38,646

Previous 53,161 27.3%

Holding current value

$1.75 Million

Previous $1.63 Million 11.82%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$30.39 - $37.66 $441,110 - $546,634	-14,515 Reduced 27.3%	38,646 $1.43 Million
Q2 2024 Aug 14, 2024	BUY	$24.69 - $40.12 $609,522 - $990,442	24,687 Added 86.7%	53,161 $1.63 Million
Q1 2024 May 15, 2024	SELL	$24.15 - $31.95 $509,106 - $673,537	-21,081 Reduced 42.54%	28,474 $828,000
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $895,458 - $1.46 Million	49,555 New	49,555 $1.37 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $345,555 - $444,639	-8,257 Reduced 48.91%	8,626 $433,000
Q2 2022 Aug 15, 2022	BUY	$25.6 - $45.23 $77,849 - $137,544	3,041 Added 21.97%	16,883 $676,000
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $122,287 - $163,637	3,669 Added 36.07%	13,842 $516,000
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $3.7 Million - $4.38 Million	-104,734 Reduced 91.15%	10,173 $405,000
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $912,888 - $1.1 Million	24,666 Added 27.33%	114,907 $4.28 Million
Q2 2021 Aug 16, 2021	BUY	$37.95 - $49.37 $2.01 Million - $2.62 Million	53,087 Added 142.88%	90,241 $3.81 Million
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $828,219 - $1.22 Million	17,697 Added 90.95%	37,154 $1.76 Million
Q4 2020 Feb 16, 2021	BUY	$47.96 - $67.64 $933,157 - $1.32 Million	19,457 New	19,457 $1.19 Million
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $258,952 - $402,412	-8,037 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $271,811 - $387,142	8,037 New	8,037 $272,000
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $375,877 - $477,540	-10,612 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$28.09 - $39.49 $245,450 - $345,063	-8,738 Reduced 45.16%	10,612 $399,000
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $249,140 - $388,451	8,352 Added 75.94%	19,350 $664,000
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $372,832 - $525,374	10,998 New	10,998 $517,000
Q1 2018 May 15, 2018	SELL	$17.46 - $32.59 $471,961 - $880,940	-27,031 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$15.14 - $20.89 $117,501 - $162,127	7,761 Added 40.28%	27,031 $451,000
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $323,928 - $416,424	19,270	19,270 $386,000

Others Institutions Holding PTCT

# of Institutions

221

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.24B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account